Biodesix, Inc.
BDSX
$24.00
$0.210.88%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 32.42% | 20.93% | 17.86% | 9.77% | 7.71% |
| Total Depreciation and Amortization | -3.39% | -2.55% | -1.78% | 1.83% | 8.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.07% | -30.34% | -41.15% | -37.48% | -44.15% |
| Change in Net Operating Assets | -111.91% | 72.78% | 101.54% | 97.07% | 93.21% |
| Cash from Operations | 33.76% | 40.78% | 52.17% | 50.48% | 40.13% |
| Capital Expenditure | 65.52% | 91.34% | 91.98% | 81.17% | 89.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.15% | 38.46% | 31.43% | 6.04% | -23.21% |
| Cash from Investing | 59.42% | 87.59% | 88.28% | 78.71% | 87.43% |
| Total Debt Issued | -100.00% | -- | -- | 0.00% | 0.00% |
| Total Debt Repaid | 60.53% | 57.78% | 58.82% | 43.14% | 24.00% |
| Issuance of Common Stock | 4,611.13% | -54.97% | -86.11% | -92.03% | -99.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -163.02% | 57.05% | 66.96% | 81.30% | 90.46% |
| Cash from Financing | 201.23% | -35.32% | -68.46% | -80.36% | -88.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 143.13% | 30.40% | -18,507.69% | -227.97% | -186.62% |